Pfizer Inc (NYSE:PFE)
| 43.79 Delayed Data As of Jan 27 |  -0.46 / -1.04%Today’s Change | 41.45 Today|||52-Week Range 56.32 | -14.54% Year-to-Date |
PFE Regular Dividend: PFE began trading ex-dividend on 01/26/23. A $0.41 dividend will be paid to shareholders of record as of 01/27/23.
Latest PFE News | Press Releases
Today’s Trading
| Previous close | 44.25 |
| Today’s open | 44.20 |
| Day’s range | 43.78 - 44.34 |
| Volume | 23,798,610 |
| Average volume (3 months) | 21,293,101 |
| Market cap | $253.0B |
Data as of 4:00pm ET, 01/27/2023
Growth & Valuation
| Earnings growth (last year) | +128.42% |
| Earnings growth (this year) | +46.77% |
| Earnings growth (next 5 years) | -5.93% |
| Revenue growth (last year) | +93.97% |
| P/E ratio | 8.4 |
| Price/Sales | 4.15 |
| Price/Book | 3.25 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +0.55 | +0.40% |
| ABBVAbbVie | -1.13 | -0.77% |
| MRKMerck | -1.45 | -1.36% |
| AZNAstraZeneca | -0.46 | -0.70% |
Data as of 4:00pm ET, 01/27/2023
Financials
| Next reporting date | January 31, 2023 |
| EPS forecast (this quarter) | $1.05 |
| Annual revenue (last year) | $81.3B |
| Annual profit (last year) | $22.1B |
| Net profit margin | 27.57% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
